| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.22 | 3e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.27 | 3e-05 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-05 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-05 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |